| Website | circulite.net |
| Category | BioTech |
| Phone | +1.201.543.2430 |
| Employees | |
| Description | cardiovascular device company |
| Total | $62.5M |
| Series C, 1/10 Forbion Capital Partners Credit Agricole Private Equity Foundation Medical Partners Oxford Bioscience Partners | $32.5M |
| Series D, 11/11 Forbion Capital Partners | $30M |
CircuLite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally-invasive micro-pumps for long-term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient’s native pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients and their families. The company’s proprietary micro-pump platform enables its PCS devices to be so small that they can be implanted superficially in a pacemaker-like pocket with endovascular or minimally-invasive surgical techniques.
